Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Invus Public Equities Advisors, Llc
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   32,130,897    

Indirect Shares

   60,240,864      
Direct Value   $161,186,668    

Indirect Value

   $112,650,416      
Total Shares   92,371,761      
Total Value   $273,837,084      


Generation Bio Co. $0 Sqz Biotechnologies Co $0 Seer, Inc. $0 Omega Therapeutics, Inc. $5,354,163 Scholar Rock Holding Corp $153,578,734 Glycomimetics Inc $2,253,770 Generation Bio Co. $0 Sqz Biotechnologies Co $0 Seer, Inc. $0 Omega Therapeutics, Inc. $5,354,163 Scholar Rock Holding Corp $153,578,734 Glycomimetics Inc $2,253,770
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    15   
    1    

     Stock price went up :
    3   
    0    
     Stock price went down :
    12   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -8.7%
 -25.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Lexicon Pharmaceuticals Inc LXRX Director, 10% Owner 2014-11-26 0 2018-06-28 60,240,864    Premium*  
            Generation Bio Co. GBIO 10% Owner 2020-06-16 2,814,191 2020-06-16 0    Premium*  
            Sqz Biotechnologies Co SQZ 10% Owner 2020-11-03 1,606,308 2020-11-03 0    Premium*  
            Seer, Inc. SEER 10% Owner 2021-02-01 5,588,366 2021-02-01 0    Premium*  
            Omega Therapeutics, Inc. OMGA 10% Owner 2021-08-03 2,273,530 2021-07-30 0    Premium*  
            Scholar Rock Holding Corp SRRK 2023-10-12 11,259,438 0    Premium*  
            Glycomimetics Inc GLYC 10% Owner 2023-02-24 8,589,064 2023-02-09 0    Premium*  
* Premium Members only  

Records found :    52         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
GBIO Generation Bio Co. 10% Owner   –       –       •   2020-06-16 4 B $19.00 $15,200,000 D/D 800,000 2,814,191 2.45 -
GBIO Generation Bio Co. 10% Owner   –       –       •   2020-06-16 4 A $0.00 $0 D/D 2,014,191 2,014,191 0 -
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-09 3 IO $0.00 $0 D/D 0 6,562,347 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-09 4 B $3.24 $37,123 D/D 11,451 6,573,798 2.37 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-15 4 B $2.16 $2,155,800 D/D 1,000,000 7,573,798 2.45 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-16 4 B $1.68 $531,129 D/D 315,266 7,889,064 2.45 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-17 4 B $1.71 $341,000 D/D 200,000 8,089,064 2.45 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-21 4 B $1.85 $92,500 D/D 50,000 8,139,064 2.45 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-22 4 B $1.79 $268,995 D/D 150,000 8,289,064 2.45 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-23 4 B $1.75 $350,760 D/D 200,000 8,489,064 2.45 %
GLYC Glycomimetics Inc 10% Owner   –       –       •   2023-02-24 4 B $1.70 $170,000 D/D 100,000 8,589,064 2.45 %
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2014-11-26 4 B $1.01 $150,000,000 I/I 149,253,731 149,253,731 2.25 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2017-11-10 4 AB $9.74 $1,418,384 I/I 145,680 939,007 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2017-11-13 4 AB $9.75 $2,097,934 I/I 215,133 1,154,140 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2017-11-14 4 AB $9.47 $2,037,847 I/I 215,133 1,369,273 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2017-11-15 4 AB $10.21 $1,334,396 I/I 130,727 1,500,000 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2017-11-17 4 AB $9.85 $492,500 I/I 50,000 1,550,000 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-05-25 4 AB $9.62 $1,334,974 I/I 138,700 1,688,700 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-05-29 4 AB $9.84 $1,450,420 I/I 147,339 1,836,039 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-05-30 4 AB $10.32 $1,521,025 I/I 147,339 1,983,378 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-05-31 4 AB $11.62 $1,712,050 I/I 147,339 2,130,717 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-06-01 4 AB $12.22 $1,800,041 I/I 147,339 2,278,056 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-06-04 4 AB $12.24 $1,490,576 I/I 121,803 2,399,859 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-06-05 4 AB $12.45 $2,156,187 I/I 173,121 2,572,980 0 -
LXRX Lexicon Pharmaceuticals I... Director   –       •       •   2018-06-06 4 AB $12.58 $1,196,370 I/I 95,079 2,668,059 0 -
  52  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us